Skip to contentB
Bio Essence Corp
B
BIOEBio Essence Corp Q3 2025 · 10-Q
Revenue$136.80K$136.80K+1.6% vs Q3 2024 Net Income$13.00K$13.00KN/M vs Q3 2024 EPS Diluted$0.00$0.00N/M vs Q3 2024 Gross Profit$95,760+18.2% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bio Essence Corp · CIK 1723059 · Engraved from SEC EDGAR
Operating Cash Flowderived$186,973−47.6% Margins · derivedGross margin70.0%+9.9 pt vs Q3 2024
Operating margin10.4%+119.1 pt vs Q3 2024
Net margin9.5%+900.1 pt vs Q3 2024
ended Sep 30, 2025 · filed Nov 12, 2025 · 43 d after period end